MARBIONC Forges Public-private Partnership

By Jenny Callison, posted Jul 23, 2014
A new partnership announced Wednesday by the University of North Carolina Wilmington gives a private company the licensing rights to a series of products developed by university researchers.
Ocis Biotechnology, a tenant in UNCW’s MARBIONC center, will use Escortin, a trademarked series of products made at MARBIONC from seaweed, in its research. Ocis hopes that Escortin carriers will be successful in delivering vitamin C directly into cells, according to UNCW’s news release.
Ocis Biotechnology is focused on creating modern therapy solutions for wounds, skin cancer and for use in ophthalmology, the release stated.
If the Escortin carriers work as hoped, Ocis’ research will explore how the controlled delivery of vitamin C to specific parts of the body spurs tissue regeneration in healing chronic wounds and vision correction, the release stated, adding, “Past studies have shown that vitamin C can regenerate, renew and repair tissue by stimulating and accelerating the body’s native tissue production mechanism.”
Lisa Day, the CEO of Ocis Biotechnology, sees promise in both the project and the resources available to her company at MARBIONC.
“We all see the future in therapeutic delivery technology, and we are looking forward to our growth and the ability to create job opportunities for UNCW graduates and the Wilmington community,” she said in the release.
Over the next several weeks, Ocis will work with a MARBIONC research team led by Andrea Bourdelais, UNCW research associate professor, to collect preliminary data for a Small Business Technology Transfer grant application, the release stated. If awarded, the grant would support research and future commercialization efforts of the Escortin-vitamin C combination.
“MARBIONC was conceived to create opportunities for UNCW exactly like the partnership we are forming with Ocis Biotechnology,” Dan Baden, MARBIONC executive director, said in the release. “If this research proves that the conjugate can successfully permeate the skin, MARBIONC and Ocis will be able to create a product that hasn’t been seen on the market before and has the potential to drastically change lives for the better.”
For their part, MARBIONC researchers have great hopes for their Escortin carriers, which they believe have the potential to greatly enhance medical research by broadening the chemicals and imaging agents that can be transported across the cell membranes, according to information on the MARBIONC website.
Ico insights



Do You Have a Strong P#$$w0rd*?

Marty Cayton - TeamLogic IT of Wilmington & Fayetteville
Dallas headshot 300x300

When Key Employees Stall Your Exit

Dallas Romanowski - Cornerstone Business Advisors
1 shaun olsen 300x300

Marco Marsala: A Cautionary Tale

Shaun Olsen - CloudWyze

Trending News

After 40 Years, Air Wilmington Could Have New Owner

Christina Haley O'Neal - Feb 19, 2018

Pollution Concerns Slow National Gypsum Incentives Discussion

Cece Nunn and Christina Haley O'Neal - Feb 19, 2018

In The Current Issue

Made: Powering Up Across Industries

Power cord manufacturer Feller LLC in Leland was founded in the U.S. in 1984....

Local Businesses Awarded AAA Distinctions Again

Three Wilmington hospitality businesses received 2018 AAA Four Diamond distinctions, a rating that less than 4 percent of thousands of annua...

Safur’s Take On Crime Prevention

Safur is developing high-tech wearable devices to help stop sexually-based crimes from happening....

Book On Business

The 2018 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!



WilmingtonBiz Expo - Keynote Lunch with John Gizdic, CEO, New Hanover Regional Medical Center
Wilmington's Most Intriguing People of 2017
2017 Health Care Heroes